AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
November 14, 2019

Step Therapy National Day of Advocacy

This week AGA and 17 other specialty physician and patient advocacy organizations partnered with the Digestive Disease National Coalition (DDNC) on an advocacy day focused on the need for step therapy reform.
Share on facebook
Share on twitter
Share on linkedin
Share on email

We met with congressional offices to seek support for patient protection guardrails in step therapy and encourage co-sponsorship of the Safe Step Act. This bipartisan legislation would create a clear process for a patient or physician to request an exception to a step therapy protocol. It also would require insurers to grant exemptions to step therapy in the following situations:

  • 1. Patient already tried and failed on a required treatment
  • 2. Delayed treatment will cause irreversible damage
  • 3. Required treatment will cause harm to the patient
  • 4. Required treatment will prevent a patient from working or fulling daily activities
  • 5. Patient is stable on their current treatment

AGA representatives and patient advocates met with the congressional offices of these legislators who serve on key committees that have jurisdiction over this issue.

  • Sen. Chris Van Hollen, D-MD
  • Sen. Tim Scott, R-SC
  • Sen. Thom Tillis, R-NC
  • Sen. Lamar Alexander, R-NC
  • Rep. Alma Adams, D-NC
  • Rep. Mark Walker, R-NC
  • Rep. Tim Walberg, R-MI

A special thanks to AGA members who contacted your legislators online. A combination of 344 tweets and emails were sent urging federal legislators to support the Safe Step Act.  

It’s not too late to advocate 

Legislators and their staff are always asking us for real-life examples from constituents about step therapy burdens to humanize the issue. Contact AGA staff at to share your story.  

Make sure your voice is heard on Capitol Hill
AGA Advocacy
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.